Adjunctive basal GLP-1-RA therapy in patients after MBS may be a promising treatment choice in weight management in addition to lifestyle changes, not only due to increased GLP-1 signaling, but also to a putative blunting effect on metabolic adaptation that occurs after MBS, increased fat oxidation, and decreased carbohydrate and protein oxidation
Can semaglutide help with other health conditions
[2] Patients should be counseled about the need for ongoing treatment, as weight regain commonly occurs upon discontinuation
The real risk to your eyesight isnt GLP-1 meds its untreated obesity, diabetes, and metabolic disease
Both 25-hydroxylases (CYP2R1 and CYP27A1) were expressed in the liver, while CYP27A1 expression was seen only in cultured hepatocytes (FL83B mouse hepatocyte cell line)
"We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many." The company noted in its second-quarter earnings call this month that compounding pharmacies, which are allowed to make versions of medications approved by the U.S